* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download The 2015 Novo Nordisk Prize Symposium on
2015–16 Zika virus epidemic wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
Ebola virus disease wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Orthohantavirus wikipedia , lookup
Influenza A virus wikipedia , lookup
West Nile fever wikipedia , lookup
Marburg virus disease wikipedia , lookup
Herpes simplex virus wikipedia , lookup
Henipavirus wikipedia , lookup
The 2015 Novo Nordisk Prize Symposium on Hepatitis C Virus (HCV) Friday the 11th of September, 2015 Lecture Hall, Novo Nordisk Foundation, Tuborg Havnevej 19, DK-2900 Hellerup, Denmark Organized by Prof. Jens Bukh, Copenhagen Hepatitis C Program (CO-HEP) and CEO Birgitte Nauntofte, Novo Nordisk Foundation 8.30 Registration 9.00 Welcome - The 2015 Novo Nordisk Prize Niels-Henrik von Holstein-Rathlou, CSO, Novo Nordisk Foundation 9.15 From Non-A, Non-B to hepatitis C virus – a historical perspective from the mentor Robert Purcell, National Institutes of Health, Bethesda, Maryland, USA 9.45 Infectious culture systems of hepatitis C virus – years in the making Jens Bukh, CO-HEP 10.15 How have humanized mice contributed to our understanding of HCV Philip Meuleman, Ghent University, Ghent, Belgium 10.50 Coffee/tea 11.15 The long journey of hepatitis C virus entry into the hepatocyte Jean Dubuisson, Institut Pasteur, Lille, France 11.50 A new view of virus-microRNA interactions: HCV, miR-122, and beyond Charles Rice, The Rockefeller University, New York, New York, USA 12.25 Viral and host factors in HCV-associated hepatocellular carcinoma Patrizia Farci, National Institutes of Health, Bethesda, Maryland, USA 13.00 Lunch 13.45 Cell culture studies of direct acting antivirals against HCV Judith Gottwein, CO-HEP 14.20 Specificity of the protective B cell response to HCV Steven Foung, Stanford University Blood Center, Palo Alto, California, USA 14.55 Role of CD8+ T cell responses in HBV and HCV infection Robert Thimme, University Hospital of Freiburg, Freiburg, Germany 15.30 Coffee/tea 15.55 Hepatitis C virus neutralizing epitopes and rational vaccine design Mansun Law, The Scripps Research Institute, La Jolla, California, USA 16.30 Comparing immunity against hepatitis viruses: what can be learned from studies of HAV and HEV Christopher Walker, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA 17.05 Closing remarks Jens Bukh, CO-HEP 17.15 End of program